EDAP TMS (EDAP)
(Delayed Data from NSDQ)
$3.05 USD
-0.03 (-0.97%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $3.09 +0.04 (1.31%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
EDAP TMS S.A. [EDAP]
Reports for Purchase
Showing records 1 - 20 ( 56 total )
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Despite Less Than Optimal Interim Data Readout HIFU Could Have Potential in Endometriosis; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Positive HIFI Data Could Boost Adoption; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Geographic Expansion to Provide Upside; Higher $19 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Optimized Entry and Exit Levels for EDAP 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Expecting a strong Q4 and Growth in 2024; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Focal One Continues to Build Momentum; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Strong Focal One Sales and HIFU Clinical Progress; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Guard Change; Expect HIFU Growth Inflection; PT Higher to $16; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Long-Term Thesis Strengthens with Record Focal One Placements in 2022; Higher $13 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Ramping Up Growth With Rising Reimbursement; Higher $12 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Higher CMS Reimbursement; Expect Sales Growth to Continue; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Strong 1Q22 Bodes Well for 2022 Growth and Beyond; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Pivotal Year for U.S. Commercialization; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Poised for Growth in 2022 and Beyond; Lower PT to $11; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Favorable Reimbursement and US Commercial Expansion to Aid Growth Sustenance
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Growth Momentum Could Continue With Improving Reimbursement; Higher $12 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Starting 2021 With a Renewed Growth Momentum; Higher $10 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: EDAP TMS S.A.
Industry: Medical - Instruments
Final CMS Rules Bode Well for HIFU Adoption; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S